1. Author response: Prospective validation of the PML risk biomarker L-selectin and influence of natalizumab extended intervals. (15th September 2020) Authors: Schwab, Nicholas; Schneider-Hohendorf, Tilman; Pignolet, Béatrice; Brassat, David; Wiendl, Heinz Journal: Neurology Issue: Volume 95:Number 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS. (September 2021) Authors: Cohen, Mikael; Mondot, Lydiane; Bucciarelli, Florence; Pignolet, Béatrice; Laplaud, David-Axel; Wiertlewski, Sandrine; Brochet, Bruno; Ruet, Aurélie; Defer, Gilles; Derache, Nathalie; Vermersch, Patrick; Zephir, Hélène; Debouverie, Marc; Mathey, Guillaume; Berger, Eric; Cappé, Chrystelle; Labauge... Journal: Multiple sclerosis Issue: Volume 27:Number 10(2021) Page Start: 1556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model. (1st February 2017) Authors: Gebauer, Christina; Pignolet, Béatrice; Yshii, Lidia; Mauré, Emilie; Bauer, Jan; Liblau, Roland Journal: Oncoimmunology Issue: Volume 6:Number 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. (6th December 2016) Authors: Pignolet, Béatrice; Schwab, Nicholas; Schneider-Hohendorf, Tilman; Bucciarelli, Florence; Biotti, Damien; Averseng-Peaureaux, Delphine; Outteryck, Olivier; Ongagna, Jean-Claude; de Sèze, Jérôme; Brochet, Bruno; Ouallet, Jean-Christophe; Debouverie, Marc; Pittion, Sophie; Defer, Gilles; Derache, N... Journal: Neurology Issue: Volume 87:Number 23(2016) Page Start: 2491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. (6th December 2016) Authors: Pignolet, Béatrice; Schwab, Nicholas; Schneider-Hohendorf, Tilman; Bucciarelli, Florence; Biotti, Damien; Averseng-Peaureaux, Delphine; Outteryck, Olivier; Ongagna, Jean-Claude; de Sèze, Jérôme; Brochet, Bruno; Ouallet, Jean-Christophe; Debouverie, Marc; Pittion, Sophie; Defer, Gilles; Derache, N... Journal: Neurology Issue: Volume 87:Number 23(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1‐integrin. Issue 12 (6th October 2015) Authors: Martin‐Blondel, Guillaume; Pignolet, Béatrice; Tietz, Silvia; Yshii, Lidia; Gebauer, Christina; Perinat, Therese; Van Weddingen, Isabelle; Blatti, Claudia; Engelhardt, Britta; Liblau, Roland Journal: European journal of immunology Issue: Volume 45:Issue 12(2015:Dec.) Page Start: 3302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PML risk stratification using anti-JCV antibody index and L-selectin. (July 2016) Authors: Schwab, Nicholas; Schneider-Hohendorf, Tilman; Pignolet, Béatrice; Spadaro, Michela; Görlich, Dennis; Meinl, Ingrid; Windhagen, Susanne; Tackenberg, Björn; Breuer, Johanna; Cantó, Ester; Kümpfel, Tania; Hohlfeld, Reinhard; Siffrin, Volker; Luessi, Felix; Posevitz-Fejfár, Anita; Montalban, Xavier;... Journal: Multiple sclerosis Issue: Volume 22:Number 8(2016) Page Start: 1048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prospective validation of the PML risk biomarker L-selectin and influence of natalizumab extended intervals. (17th September 2019) Authors: Schwab, Nicholas; Schneider-Hohendorf, Tilman; Pignolet, Béatrice; Bucciarelli, Florence; Scandella, Lise; Ciron, Jonathan; Biotti, Damien; Lebrun-Frenay, Christine; Mathey, Guillaume; Clavelou, Pierre; Pelletier, Jean; Ostkamp, Patrick; Meinl, Ingrid; Windhagen, Susanne; Klotz, Luisa; Gross, Cat... Journal: Neurology Issue: Volume 93:Number 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reply. Issue 4 (4th October 2017) Authors: Fissolo, Nicolas; Pignolet, Béatrice; Brassat, David; Comabella, Manuel Journal: Annals of neurology Issue: Volume 82:Issue 4(2017) Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values. Issue 1 (February 2016) Authors: Schwab, Nicholas; Schneider-Hohendorf, Tilman; Pignolet, Béatrice; Breuer, Johanna; Gross, Catharina C.; Göbel, Kerstin; Brassat, David; Wiendl, Heinz Journal: Neurology Issue: Volume 3:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗